The aim with study is to provide adjunctive therapy with vitamin D and phenylbutyrate
together with standard anti-tuberculosis treatment to significantly improve clinical recovery
among patients with untreated, active pulmonary tuberculosis.
Phase:
Phase 2
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Addis Ababa University Armauer Hansen Research Institute, Ethiopia
Treatments:
4-phenylbutyric acid Anti-Infective Agents Cholecalciferol Ergocalciferols Vitamin D Vitamins